Search any NSE / BSE company

Live price, peer comparison, QoQ growth, ROE/ROI, dividend, news & AI recommendation

Sun Pharma

SUNPHARMA · Healthcare · Drug Manufacturers - Specialty & Generic

sunpharma.com

₹1,748.00

-0.57%BuyStable

5-min paceSlow· 0.00%/5m

Open ₹1,757.40·Day ₹1,765.40 / ₹1,735.20·52W ₹2,046.90 / ₹1,583.70

LIVE · updated 14:49:23 IST · NSE

52W LOW ₹1,583.7035% of 52W range52W HIGH ₹2,046.90

Now ₹1,748.00Today ₹1,735.20 – ₹1,765.40

TECHNICAL RATING · LIVESell

RSI 37.2vs SMA50 -5.5%vs SMA200 -3.3%

P/E RATIO (LIVE)

34.67

MARKET CAP

₹4,18,194 Cr

VOLUME

10,64,528

SALES Jun 2026

₹15,300 Cr

NET PROFIT Jun 2026

₹2,895 Cr

P/B · EPS

— · 50.41

ROE

14.47%

ROI / ROA

—

SALES GROWTH QoQ

4.7%

PROFIT GROWTH QoQ

6.7%

PROFIT MARGIN

20.19%

DIVIDEND YIELD

0.92%

BETA

0.14

TARGET UPSIDE

+24.39%

ANALYSTS

TREND, SEASONALITY & HEALTH

Downtrend₹1,748.00 vs SMA20 1,785.07 · SMA50 1,850.33 · SMA200 1,808.08(-3.3% vs 200DMA)1W -0.61% · 1M -3.78%

UPTREND MONTHS · 10-YEAR SEASONALITYHistorically rises in: Feb, Mar, May, Jun

Jan

-0.86%

Feb

+1.92%

Mar

+3.73%

Apr

-5.68%

May

+2.96%

Jun

+7.23%

Jul

+0.19%

Aug

-0.74%

Sep

+0.24%

Oct

+0.24%

Nov

+0.71%

Dec

-0.2%

PLEDGED

0% / none

DEBT / EQUITY

0.06

MF HOLDING

22.27% *

PROMOTER

52.68%

MANAGEMENT

Good

* MF holding approximated by total DII (domestic institutions incl. mutual funds) holding.

TRADE-HOURS SPEED SCALE

SLOWMEDIUMFAST

TODAY · 23 Oct 2026

5-DAY AVERAGE · 5 SESSIONS

09:1511:1513:1515:15

Colour = avg absolute 5-min price move per 15-min slot · Slow <0.10%, Medium <0.35%, Fast ≥0.35%.

VOLUME · DELIVERY · HOLDINGS

VOLUME TODAY

NORMAL0.68× of 20d avg

10,64,528.00 shares · avg 15,70,512.00

DELIVERY % · 2026-10-23

MEDIUM59.98% taken delivery

20d avg 62.42% · below its own average

PROMOTER52.68%-1.8

PUBLIC10.7%+1.89

MUTUAL FUND *22.27%+0.21

FII14.36%-0.18

QUARTERLY SALES & PROFIT

source: tradingview · Jun 2026

SALES · Jun 2026

₹15,300 Cr

QoQ +4.7%YoY +10.5%

NET PROFIT · Jun 2026

₹2,895 Cr

QoQ +6.7%YoY +27%

OPERATING PROFIT · MARGIN

₹4,296 Cr

margin 28%

EPS (₹)

12.06

latest quarter

Net profit (₹ Cr)
Sales (₹ Cr)

₹ CR	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	13,291	13,675	12,959	13,851	14,478	15,521	14,612	15,300
Operating profit	3,811	4,192	3,425	4,073	4,097	4,795	3,527	4,296
OPM %	29%	31%	26%	29%	28%	31%	24%	28%
Net profit	3,040	2,903	2,150	2,279	3,118	3,369	2,714	2,895
EPS ₹	12.67	12.1	8.96	9.5	13	14.04	11.31	12.06
Profit YoY	+28%	+15%	-19%	-19.6%	+2.6%	+16%	+26.2%	+27%

COMPANY PROFILE

sunpharma.com

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including…

HealthcareDrug Manufacturers - Specialty & GenericMumbai47,000 employees

DIRECTORS & KEY MANAGEMENT

Mr. Dilip Shantilal Shanghvi

Executive Chairman of the Board

Mr. Kirti Wardhaman Ganorkar

Managing Director

Mr. Aalok Dilip Shanghvi

COO, Head of Global Generics R&D, Business Devp., and Whole Time Director

Ms. Vidhi Dilip Shanghvi

Whole-time Director

Ms. Jayashree Satagopan

Executive VP & CFO

Mr. Dheeraj Prasad Sinha BE

EVP & Chief Information Officer

Dr. Abhishek Sharma

VP, Head of Investor Relations & Strategic Projects

Mr. Anoop Deshpande

Company Secretary & Compliance Officer

Mr. Kalyanasundaram Subramanian

Director of Corporate Development

Ms. Sana Shaikh

Head of Marketing

5-YEAR GROWTH STATISTICS

source: tradingview

SALES (₹ Cr)CAGR +11.71%

FY21	FY22	FY23	FY24	FY25	FY26
33,498	38,654	43,886	47,863	52,153	58,263
—	+15%	+14%	+9%	+9%	+12%

NET PROFIT (₹ Cr)CAGR +31.64%

FY21	FY22	FY23	FY24	FY25	FY26
2,904	3,273	8,474	9,576	10,929	11,479
—	+13%	+159%	+13%	+14%	+5%

EPS (₹)CAGR +31.64%

FY21	FY22	FY23	FY24	FY25	FY26
12.1	13.6	35.3	39.9	45.6	47.8
—	+13%	+159%	+13%	+14%	+5%

SHAREHOLDING PATTERN

as of Sep 2026 · refreshed daily

52.68%PROMOTER

Promoter 52.68%FII 14.36%DII 22.27%Public 10.7%

ANALYST VIEW & TARGET

32 analysts

Strong Buy

Avg target ₹2,188.70▲ 25.21% upside

Strong Buy 20Buy 9Hold 0Sell 2Strong Sell 1

Low ₹1,830.00Now ₹1,748.00 · Avg ₹2,188.70High ₹2,437.00

BUSINESS MIX · CLIENTS · ORDER BOOK · GUIDANCE

AI-ESTIMATED

AI unavailable — AI budget exhausted — top up the Universal Key to enable.

CORPORATE ACTIONS

No upcoming dividend / bonus / split / rights scheduled.

PAST 12 MONTHS

DIVIDENDDividend - Rs 5 Per Shareex 07 Jul 26

DIVIDENDInterim Dividend - Rs 11 Per Shareex 05 Feb 26

AI RECOMMENDATION

Pick a model and generate an AI recommendation with future outlook & present performance.

Generated by AI · informational only, not investment advice.

SUNPHARMA · 4H CANDLES LIVE · 1s

Auto resistance from lifetime peak

Amber = auto resistance trendline anchored at the lifetime peak, touching the highest swing highs to date. Prices re-anchor to live NSE/BSE every 30s with per-second micro-ticks. Use “Draw trendline” to plot your own by clicking two points.

PEER COMPARISONPeer Avg P/E 28.44 · ROE 16%

COMPANY	PRICE	CHG%	P/E	ROE	SALES QoQ	PROFIT QoQ	VS PEERS
SUNPHARMA (this)	₹1,748.00	-0.57%	34.67	14.47%	4.7%	6.7%	Premium
CIPLA CIPLA LTD	₹1,338.00	+0.53%	32.09	9.78%	3.5%	-39.2%	Premium
LUPIN LUPIN LIMITED	₹1,928.90	+0.36%	15.98	24.59%	32%	16.1%	Discount
DRREDDY DR. REDDY S LABORATORIES	₹1,229.50	-0.77%	36.6	7.34%	-1.5%	-35.6%	Premium
HCLTECH HCL TECHNOLOGIES LTD	₹1,422.20	+0.04%	21.04	24.65%	2.2%	10.7%	Discount
LT Larsen & Toubro	₹3,647.00	+0.24%	30.25	15.17%	8.1%	14%	Premium